Cubist Systematic Strategies’s AtriCure ATRC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-231,480
| Closed | -$7.47M | – | 1537 |
|
2025
Q1 | $7.47M | Buy |
+231,480
| New | +$7.47M | 0.05% | 322 |
|
2024
Q2 | – | Sell |
-152,931
| Closed | -$4.65M | – | 1491 |
|
2024
Q1 | $4.65M | Sell |
152,931
-60,470
| -28% | -$1.84M | 0.03% | 533 |
|
2023
Q4 | $7.62M | Buy |
213,401
+130,522
| +157% | +$4.66M | 0.05% | 319 |
|
2023
Q3 | $3.63M | Sell |
82,879
-51,798
| -38% | -$2.27M | 0.03% | 555 |
|
2023
Q2 | $6.65M | Buy |
134,677
+23,767
| +21% | +$1.17M | 0.04% | 394 |
|
2023
Q1 | $4.6M | Buy |
110,910
+54,074
| +95% | +$2.24M | 0.03% | 652 |
|
2022
Q4 | $2.52M | Buy |
56,836
+10,142
| +22% | +$450K | 0.01% | 1158 |
|
2022
Q3 | $1.83M | Buy |
46,694
+16,145
| +53% | +$631K | 0.01% | 1657 |
|
2022
Q2 | $1.25M | Buy |
30,549
+26,644
| +682% | +$1.09M | 0.01% | 1947 |
|
2022
Q1 | $256K | Sell |
3,905
-13,534
| -78% | -$887K | ﹤0.01% | 2904 |
|
2021
Q4 | $1.21M | Buy |
17,439
+12,353
| +243% | +$859K | 0.01% | 1769 |
|
2021
Q3 | $354K | Sell |
5,086
-5,401
| -52% | -$376K | ﹤0.01% | 2250 |
|
2021
Q2 | $832K | Buy |
+10,487
| New | +$832K | 0.01% | 1705 |
|
2021
Q1 | – | Sell |
-13,105
| Closed | -$730K | – | 2822 |
|
2020
Q4 | $730K | Buy |
+13,105
| New | +$730K | 0.01% | 1568 |
|
2020
Q3 | – | Sell |
-29,551
| Closed | -$1.33M | – | 2479 |
|
2020
Q2 | $1.33M | Buy |
29,551
+20,267
| +218% | +$911K | 0.02% | 1015 |
|
2020
Q1 | $312K | Buy |
9,284
+6,149
| +196% | +$207K | 0.01% | 1496 |
|
2019
Q4 | $102K | Sell |
3,135
-12,214
| -80% | -$397K | ﹤0.01% | 2184 |
|
2019
Q3 | $383K | Buy |
+15,349
| New | +$383K | 0.01% | 1423 |
|
2018
Q4 | – | Sell |
-421
| Closed | -$15K | – | 2039 |
|
2018
Q3 | $15K | Buy |
+421
| New | +$15K | ﹤0.01% | 1786 |
|
2017
Q4 | – | Sell |
-2,961
| Closed | -$66K | – | 1899 |
|
2017
Q3 | $66K | Buy |
2,961
+660
| +29% | +$14.7K | ﹤0.01% | 1699 |
|
2017
Q2 | $56K | Buy |
+2,301
| New | +$56K | ﹤0.01% | 1533 |
|